

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.35614137 |
| 2 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.35614137 |
| 3 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.11672908 |
| 4 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.57677282 |
| 5 | vascular endothelial growth factor signaling pathway (GO:0038084) | 3.56593940 |
| 6 | apoptotic cell clearance (GO:0043277) | 3.51016099 |
| 7 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.42038122 |
| 8 | response to laminar fluid shear stress (GO:0034616) | 3.36239083 |
| 9 | cell adhesion mediated by integrin (GO:0033627) | 3.32785209 |
| 10 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.30746148 |
| 11 | protein heterotrimerization (GO:0070208) | 3.28552219 |
| 12 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.21251267 |
| 13 | endothelium development (GO:0003158) | 3.18942390 |
| 14 | basement membrane organization (GO:0071711) | 3.17059490 |
| 15 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 3.14256332 |
| 16 | hypotonic response (GO:0006971) | 3.13212867 |
| 17 | keratan sulfate catabolic process (GO:0042340) | 3.10851381 |
| 18 | negative regulation of fibrinolysis (GO:0051918) | 3.10519641 |
| 19 | skin morphogenesis (GO:0043589) | 3.09058817 |
| 20 | endodermal cell differentiation (GO:0035987) | 3.08313462 |
| 21 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 3.07327739 |
| 22 | macrophage activation involved in immune response (GO:0002281) | 3.05493308 |
| 23 | collagen fibril organization (GO:0030199) | 3.02961925 |
| 24 | endothelial tube morphogenesis (GO:0061154) | 3.01887450 |
| 25 | morphogenesis of an endothelium (GO:0003159) | 3.01887450 |
| 26 | positive regulation of receptor recycling (GO:0001921) | 3.01554393 |
| 27 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.97653257 |
| 28 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.97653257 |
| 29 | modulation by symbiont of host immune response (GO:0052553) | 2.97653257 |
| 30 | positive regulation by symbiont of host defense response (GO:0052509) | 2.97653257 |
| 31 | modulation by symbiont of host defense response (GO:0052031) | 2.97653257 |
| 32 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.97653257 |
| 33 | substrate-dependent cell migration (GO:0006929) | 2.94745727 |
| 34 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.91156694 |
| 35 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.89693338 |
| 36 | response to fluid shear stress (GO:0034405) | 2.89621662 |
| 37 | regulation of gamma-delta T cell activation (GO:0046643) | 2.88914096 |
| 38 | positive thymic T cell selection (GO:0045059) | 2.88858446 |
| 39 | blood vessel maturation (GO:0001955) | 2.88136209 |
| 40 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.87893685 |
| 41 | wound healing, spreading of epidermal cells (GO:0035313) | 2.86680138 |
| 42 | barbed-end actin filament capping (GO:0051016) | 2.86625506 |
| 43 | positive regulation of extracellular matrix organization (GO:1903055) | 2.85413641 |
| 44 | lymph vessel development (GO:0001945) | 2.84780634 |
| 45 | negative regulation of granulocyte differentiation (GO:0030853) | 2.81886171 |
| 46 | endothelial cell chemotaxis (GO:0035767) | 2.81494316 |
| 47 | positive regulation of histone deacetylation (GO:0031065) | 2.80868308 |
| 48 | protein localization to endosome (GO:0036010) | 2.80024196 |
| 49 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.79743630 |
| 50 | germ cell migration (GO:0008354) | 2.79477858 |
| 51 | low-density lipoprotein particle clearance (GO:0034383) | 2.78566746 |
| 52 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 2.77743207 |
| 53 | growth hormone receptor signaling pathway (GO:0060396) | 2.75207143 |
| 54 | angiogenesis involved in wound healing (GO:0060055) | 2.74541131 |
| 55 | renal filtration (GO:0097205) | 2.69932371 |
| 56 | mannose metabolic process (GO:0006013) | 2.69523283 |
| 57 | tolerance induction (GO:0002507) | 2.67946651 |
| 58 | hemidesmosome assembly (GO:0031581) | 2.62233823 |
| 59 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.62020658 |
| 60 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.60711175 |
| 61 | collagen metabolic process (GO:0032963) | 2.60539971 |
| 62 | negative regulation of cell killing (GO:0031342) | 2.59138565 |
| 63 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.59138565 |
| 64 | negative regulation of complement activation (GO:0045916) | 2.58859585 |
| 65 | cell migration involved in sprouting angiogenesis (GO:0002042) | 2.58744140 |
| 66 | regulation of macrophage cytokine production (GO:0010935) | 2.58534608 |
| 67 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition | 2.57495420 |
| 68 | collagen catabolic process (GO:0030574) | 2.55827436 |
| 69 | negative regulation of protein activation cascade (GO:2000258) | 2.54159435 |
| 70 | cellular extravasation (GO:0045123) | 2.52563038 |
| 71 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.52004753 |
| 72 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.51907266 |
| 73 | glomerular filtration (GO:0003094) | 2.51322373 |
| 74 | regulation of extracellular matrix disassembly (GO:0010715) | 2.49605758 |
| 75 | negative regulation of anoikis (GO:2000811) | 2.49433783 |
| 76 | multicellular organismal macromolecule metabolic process (GO:0044259) | 2.49053197 |
| 77 | surfactant homeostasis (GO:0043129) | 2.48564710 |
| 78 | establishment of endothelial barrier (GO:0061028) | 2.47336726 |
| 79 | negative regulation of fatty acid transport (GO:2000192) | 2.45839785 |
| 80 | stress fiber assembly (GO:0043149) | 2.44860662 |
| 81 | regulation of cholesterol storage (GO:0010885) | 2.44661133 |
| 82 | detection of other organism (GO:0098543) | 2.44352317 |
| 83 | regulation of necroptotic process (GO:0060544) | 2.43155769 |
| 84 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.43114888 |
| 85 | detection of molecule of bacterial origin (GO:0032490) | 2.42592791 |
| 86 | blood vessel endothelial cell migration (GO:0043534) | 2.42446301 |
| 87 | positive regulation of interferon-alpha production (GO:0032727) | 2.40484081 |
| 88 | multicellular organismal catabolic process (GO:0044243) | 2.39346933 |
| 89 | detection of external biotic stimulus (GO:0098581) | 2.38697483 |
| 90 | regulation of plasminogen activation (GO:0010755) | 2.37921756 |
| 91 | fibril organization (GO:0097435) | 2.37887026 |
| 92 | cellular response to growth hormone stimulus (GO:0071378) | 2.37505378 |
| 93 | thymic T cell selection (GO:0045061) | 2.37401044 |
| 94 | pinocytosis (GO:0006907) | 2.36075268 |
| 95 | regulation of extracellular matrix organization (GO:1903053) | 2.36039113 |
| 96 | axon extension involved in axon guidance (GO:0048846) | 2.35976034 |
| 97 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 2.35976034 |
| 98 | integrin-mediated signaling pathway (GO:0007229) | 2.35336341 |
| 99 | regulation of apoptotic cell clearance (GO:2000425) | 2.35275780 |
| 100 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.34809757 |
| 101 | cell-substrate junction assembly (GO:0007044) | 2.34688576 |
| 102 | multicellular organismal metabolic process (GO:0044236) | 2.34423916 |
| 103 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.34094337 |
| 104 | substrate adhesion-dependent cell spreading (GO:0034446) | 2.32609534 |
| 105 | extracellular matrix disassembly (GO:0022617) | 2.32570929 |
| 106 | hyaluronan catabolic process (GO:0030214) | 2.31724485 |
| 107 | glomerular basement membrane development (GO:0032836) | 2.31286802 |
| 108 | cortical actin cytoskeleton organization (GO:0030866) | 2.30938498 |
| 109 | response to interleukin-15 (GO:0070672) | 2.30017622 |
| 110 | regulation of complement activation (GO:0030449) | 2.29892829 |
| 111 | regulation of interferon-alpha production (GO:0032647) | 2.29848668 |
| 112 | regulation of fibrinolysis (GO:0051917) | 2.28586528 |
| 113 | negative regulation of stress fiber assembly (GO:0051497) | 2.27794783 |
| 114 | negative regulation of humoral immune response (GO:0002921) | 2.27057864 |
| 115 | glomerular visceral epithelial cell development (GO:0072015) | 2.26884207 |
| 116 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 2.26717652 |
| 117 | positive regulation of blood coagulation (GO:0030194) | 2.26637787 |
| 118 | positive regulation of hemostasis (GO:1900048) | 2.26637787 |
| 119 | positive regulation of p38MAPK cascade (GO:1900745) | 2.26447694 |
| 120 | venous blood vessel morphogenesis (GO:0048845) | 2.26401112 |
| 121 | negative thymic T cell selection (GO:0045060) | 2.25010161 |
| 122 | embryonic process involved in female pregnancy (GO:0060136) | 2.24944858 |
| 123 | extracellular fibril organization (GO:0043206) | 2.23785639 |
| 124 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.22622812 |
| 125 | negative regulation of phagocytosis (GO:0050765) | 2.22328390 |
| 126 | regulation of protein activation cascade (GO:2000257) | 2.21887330 |
| 127 | positive regulation of macrophage cytokine production (GO:0060907) | 2.21859292 |
| 128 | regulation of macrophage chemotaxis (GO:0010758) | 2.21155943 |
| 129 | negative T cell selection (GO:0043383) | 2.20699793 |
| 130 | negative regulation of protein autophosphorylation (GO:0031953) | 2.20527243 |
| 131 | platelet-derived growth factor receptor signaling pathway (GO:0048008) | 2.20516955 |
| 132 | membrane raft organization (GO:0031579) | 2.19485996 |
| 133 | hepatocyte apoptotic process (GO:0097284) | 2.19096675 |
| 134 | regulation of metalloenzyme activity (GO:0048552) | 2.18747796 |
| 135 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.18741038 |
| 136 | detection of biotic stimulus (GO:0009595) | 2.18217945 |
| 137 | regulation of anoikis (GO:2000209) | 2.16475281 |
| 138 | negative regulation of necroptotic process (GO:0060546) | 2.16439085 |
| 139 | sprouting angiogenesis (GO:0002040) | 2.16032268 |
| 140 | detection of bacterium (GO:0016045) | 2.14961081 |
| 141 | cell-substrate adherens junction assembly (GO:0007045) | 2.14518039 |
| 142 | focal adhesion assembly (GO:0048041) | 2.14518039 |
| 143 | wound healing, spreading of cells (GO:0044319) | 2.14036889 |
| 144 | chondrocyte proliferation (GO:0035988) | 2.13748195 |
| 145 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.13555494 |
| 146 | regulation of transforming growth factor beta1 production (GO:0032908) | 2.13510749 |
| 147 | platelet degranulation (GO:0002576) | 2.12614603 |
| 148 | positive regulation of coagulation (GO:0050820) | 2.12022936 |
| 149 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.11219136 |
| 150 | mesodermal cell differentiation (GO:0048333) | 2.10826680 |
| 151 | negative regulation of interleukin-12 production (GO:0032695) | 2.10817437 |
| 152 | peptide catabolic process (GO:0043171) | 2.09155623 |
| 153 | cell migration involved in heart development (GO:0060973) | 2.08618057 |
| 154 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.07236623 |
| 155 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.05891127 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.36647761 |
| 2 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.81597611 |
| 3 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.60274862 |
| 4 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.39021629 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.04409209 |
| 6 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.98798802 |
| 7 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.93739990 |
| 8 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.85430357 |
| 9 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.80579024 |
| 10 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.44318063 |
| 11 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.36378386 |
| 12 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.35082629 |
| 13 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.28967866 |
| 14 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.25779260 |
| 15 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.21475886 |
| 16 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.17815229 |
| 17 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 2.16425040 |
| 18 | * RUNX_20019798_ChIP-Seq_JUKART_Human | 2.16155608 |
| 19 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.14709375 |
| 20 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.11752209 |
| 21 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.02600690 |
| 22 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.96209685 |
| 23 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.95094290 |
| 24 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.93268965 |
| 25 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.93213025 |
| 26 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.91647912 |
| 27 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.91440661 |
| 28 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.90282689 |
| 29 | MYC_22102868_ChIP-Seq_BL_Human | 1.82872798 |
| 30 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.80186629 |
| 31 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.79032155 |
| 32 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.77793612 |
| 33 | * MAF_26560356_Chip-Seq_TH1_Human | 1.77657511 |
| 34 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.76502737 |
| 35 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.72482278 |
| 36 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.71836809 |
| 37 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.70162603 |
| 38 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.65758330 |
| 39 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.62620010 |
| 40 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.60443295 |
| 41 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.60367672 |
| 42 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.58980754 |
| 43 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.56402270 |
| 44 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.55940329 |
| 45 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.55631920 |
| 46 | * MYB_26560356_Chip-Seq_TH2_Human | 1.55179331 |
| 47 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.52932862 |
| 48 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.49430115 |
| 49 | * CJUN_26792858_Chip-Seq_BT549_Human | 1.48055392 |
| 50 | SPI1_23127762_ChIP-Seq_K562_Human | 1.47064662 |
| 51 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.45110711 |
| 52 | UTX_26944678_Chip-Seq_JUKART_Human | 1.42892274 |
| 53 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.42572634 |
| 54 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.42345751 |
| 55 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.41220724 |
| 56 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.40563538 |
| 57 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.36873864 |
| 58 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.36873864 |
| 59 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.36553414 |
| 60 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.34614126 |
| 61 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.34019217 |
| 62 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.33565863 |
| 63 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.33162854 |
| 64 | * MYB_26560356_Chip-Seq_TH1_Human | 1.32523624 |
| 65 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.30772221 |
| 66 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.22323747 |
| 67 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.22136500 |
| 68 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.19697810 |
| 69 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.19670635 |
| 70 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.19488952 |
| 71 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.19441637 |
| 72 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.19198373 |
| 73 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.18900180 |
| 74 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.18900180 |
| 75 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.18862087 |
| 76 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.18838844 |
| 77 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.17967708 |
| 78 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.17646640 |
| 79 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.17494374 |
| 80 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.17099421 |
| 81 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.16652951 |
| 82 | GATA1_22025678_ChIP-Seq_K562_Human | 1.16504755 |
| 83 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.16406622 |
| 84 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.16251092 |
| 85 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.15402802 |
| 86 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.14720215 |
| 87 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.14625646 |
| 88 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.14369512 |
| 89 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.13935422 |
| 90 | * JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.13499396 |
| 91 | * FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.12697117 |
| 92 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.11847487 |
| 93 | * BRD4_25478319_ChIP-Seq_HGPS_Human | 1.11625765 |
| 94 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.11529694 |
| 95 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.11483271 |
| 96 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.10821738 |
| 97 | GATA1_19941826_ChIP-Seq_K562_Human | 1.10637926 |
| 98 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.09908450 |
| 99 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.09481420 |
| 100 | * NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.09151883 |
| 101 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.08371403 |
| 102 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.08270923 |
| 103 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.08045651 |
| 104 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.07867873 |
| 105 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.07303856 |
| 106 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.06076019 |
| 107 | GATA2_19941826_ChIP-Seq_K562_Human | 1.05970033 |
| 108 | * JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.05558565 |
| 109 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.05000971 |
| 110 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.04964195 |
| 111 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.04632208 |
| 112 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.03831440 |
| 113 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.02276120 |
| 114 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.01973533 |
| 115 | KDM2B_26808549_Chip-Seq_K562_Human | 0.96770922 |
| 116 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.95664149 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008438_abnormal_cutaneous_collagen | 4.94593557 |
| 2 | MP0005275_abnormal_skin_tensile | 3.17133779 |
| 3 | MP0003705_abnormal_hypodermis_morpholog | 2.88525796 |
| 4 | MP0003300_gastrointestinal_ulcer | 2.64368495 |
| 5 | MP0003279_aneurysm | 2.55316049 |
| 6 | MP0001958_emphysema | 2.46689145 |
| 7 | MP0006054_spinal_hemorrhage | 2.44590253 |
| 8 | MP0010368_abnormal_lymphatic_system | 2.23311739 |
| 9 | MP0003566_abnormal_cell_adhesion | 2.22303594 |
| 10 | MP0004272_abnormal_basement_membrane | 2.13844784 |
| 11 | MP0003191_abnormal_cellular_cholesterol | 2.01831702 |
| 12 | MP0005503_abnormal_tendon_morphology | 2.00973070 |
| 13 | MP0003303_peritoneal_inflammation | 2.00490770 |
| 14 | MP0001835_abnormal_antigen_presentation | 1.94800225 |
| 15 | MP0001879_abnormal_lymphatic_vessel | 1.94166015 |
| 16 | MP0003724_increased_susceptibility_to | 1.92490345 |
| 17 | MP0003436_decreased_susceptibility_to | 1.79529653 |
| 18 | MP0005023_abnormal_wound_healing | 1.70773285 |
| 19 | MP0002166_altered_tumor_susceptibility | 1.69701683 |
| 20 | MP0000685_abnormal_immune_system | 1.68824249 |
| 21 | MP0005058_abnormal_lysosome_morphology | 1.66762939 |
| 22 | MP0005451_abnormal_body_composition | 1.60249740 |
| 23 | MP0005387_immune_system_phenotype | 1.59327183 |
| 24 | MP0001790_abnormal_immune_system | 1.59327183 |
| 25 | MP0001533_abnormal_skeleton_physiology | 1.57681046 |
| 26 | MP0010352_gastrointestinal_tract_polyps | 1.57163719 |
| 27 | MP0002877_abnormal_melanocyte_morpholog | 1.53442821 |
| 28 | MP0003091_abnormal_cell_migration | 1.50842595 |
| 29 | MP0003045_fibrosis | 1.50653203 |
| 30 | MP0000767_abnormal_smooth_muscle | 1.49878303 |
| 31 | MP0002060_abnormal_skin_morphology | 1.48873313 |
| 32 | MP0001800_abnormal_humoral_immune | 1.46506262 |
| 33 | MP0006082_CNS_inflammation | 1.46335963 |
| 34 | MP0002933_joint_inflammation | 1.46065806 |
| 35 | MP0003950_abnormal_plasma_membrane | 1.45249072 |
| 36 | MP0002452_abnormal_antigen_presenting | 1.42042739 |
| 37 | MP0005000_abnormal_immune_tolerance | 1.40664629 |
| 38 | MP0002254_reproductive_system_inflammat | 1.40427604 |
| 39 | MP0002998_abnormal_bone_remodeling | 1.40349576 |
| 40 | MP0002419_abnormal_innate_immunity | 1.38921244 |
| 41 | MP0009278_abnormal_bone_marrow | 1.38380388 |
| 42 | MP0004510_myositis | 1.37663351 |
| 43 | MP0005671_abnormal_response_to | 1.37061457 |
| 44 | MP0000343_altered_response_to | 1.36955388 |
| 45 | MP0003828_pulmonary_edema | 1.36144181 |
| 46 | MP0006138_congestive_heart_failure | 1.34928257 |
| 47 | MP0008260_abnormal_autophagy | 1.34312062 |
| 48 | MP0009384_cardiac_valve_regurgitation | 1.33634002 |
| 49 | MP0004947_skin_inflammation | 1.32676766 |
| 50 | MP0003448_altered_tumor_morphology | 1.29749992 |
| 51 | MP0000465_gastrointestinal_hemorrhage | 1.28847130 |
| 52 | MP0005409_darkened_coat_color | 1.28425934 |
| 53 | MP0005360_urolithiasis | 1.27014862 |
| 54 | MP0008004_abnormal_stomach_pH | 1.25065579 |
| 55 | MP0002006_tumorigenesis | 1.21693612 |
| 56 | MP0002723_abnormal_immune_serum | 1.20295684 |
| 57 | MP0005464_abnormal_platelet_physiology | 1.19812946 |
| 58 | MP0004185_abnormal_adipocyte_glucose | 1.19752969 |
| 59 | MP0002420_abnormal_adaptive_immunity | 1.19633906 |
| 60 | MP0003172_abnormal_lysosome_physiology | 1.18794952 |
| 61 | MP0001819_abnormal_immune_cell | 1.18777723 |
| 62 | MP0005670_abnormal_white_adipose | 1.18641510 |
| 63 | MP0002405_respiratory_system_inflammati | 1.17832947 |
| 64 | MP0005076_abnormal_cell_differentiation | 1.17391627 |
| 65 | MP0000733_abnormal_muscle_development | 1.17038320 |
| 66 | MP0003763_abnormal_thymus_physiology | 1.16072754 |
| 67 | MP0005025_abnormal_response_to | 1.14426977 |
| 68 | MP0010155_abnormal_intestine_physiology | 1.13964866 |
| 69 | MP0005165_increased_susceptibility_to | 1.13001258 |
| 70 | MP0005257_abnormal_intraocular_pressure | 1.12937360 |
| 71 | MP0000249_abnormal_blood_vessel | 1.12147797 |
| 72 | MP0001873_stomach_inflammation | 1.10647701 |
| 73 | MP0000751_myopathy | 1.10126606 |
| 74 | MP0005390_skeleton_phenotype | 1.09951361 |
| 75 | MP0004808_abnormal_hematopoietic_stem | 1.08146258 |
| 76 | MP0002148_abnormal_hypersensitivity_rea | 1.07748937 |
| 77 | MP0000858_altered_metastatic_potential | 1.07310704 |
| 78 | MP0010234_abnormal_vibrissa_follicle | 1.07090288 |
| 79 | MP0009785_altered_susceptibility_to | 1.06050781 |
| 80 | MP0005167_abnormal_blood-brain_barrier | 1.05903446 |
| 81 | MP0004883_abnormal_blood_vessel | 1.05164496 |
| 82 | MP0003453_abnormal_keratinocyte_physiol | 1.04805381 |
| 83 | MP0005595_abnormal_vascular_smooth | 1.03265056 |
| 84 | MP0001845_abnormal_inflammatory_respons | 1.00807383 |
| 85 | MP0009840_abnormal_foam_cell | 0.99815852 |
| 86 | MP0001851_eye_inflammation | 0.99729536 |
| 87 | MP0003075_altered_response_to | 0.98816014 |
| 88 | MP0005164_abnormal_response_to | 0.98588960 |
| 89 | MP0002168_other_aberrant_phenotype | 0.97801127 |
| 90 | MP0002396_abnormal_hematopoietic_system | 0.97591701 |
| 91 | MP0005508_abnormal_skeleton_morphology | 0.95982951 |
| 92 | MP0002138_abnormal_hepatobiliary_system | 0.95541826 |
| 93 | MP0001243_abnormal_dermal_layer | 0.95308491 |
| 94 | MP0005623_abnormal_meninges_morphology | 0.94912127 |
| 95 | MP0002133_abnormal_respiratory_system | 0.93703757 |
| 96 | MP0005388_respiratory_system_phenotype | 0.93703757 |
| 97 | MP0004130_abnormal_muscle_cell | 0.91642773 |
| 98 | MP0000716_abnormal_immune_system | 0.89746226 |
| 99 | MP0005666_abnormal_adipose_tissue | 0.88167746 |
| 100 | MP0009333_abnormal_splenocyte_physiolog | 0.88103833 |
| 101 | MP0002398_abnormal_bone_marrow | 0.87508871 |
| 102 | MP0002295_abnormal_pulmonary_circulatio | 0.87492989 |
| 103 | MP0002128_abnormal_blood_circulation | 0.86734249 |
| 104 | MP0004084_abnormal_cardiac_muscle | 0.85396033 |
| 105 | MP0001915_intracranial_hemorrhage | 0.84848611 |
| 106 | MP0003795_abnormal_bone_structure | 0.84778612 |
| 107 | MP0000003_abnormal_adipose_tissue | 0.83551349 |
| 108 | MP0000013_abnormal_adipose_tissue | 0.83515365 |
| 109 | MP0003868_abnormal_feces_composition | 0.83289828 |
| 110 | MP0000689_abnormal_spleen_morphology | 0.82666023 |
| 111 | MP0001853_heart_inflammation | 0.82237079 |
| 112 | MP0000604_amyloidosis | 0.82076793 |
| 113 | MP0001849_ear_inflammation | 0.81840667 |
| 114 | MP0005375_adipose_tissue_phenotype | 0.81823748 |
| 115 | MP0005397_hematopoietic_system_phenotyp | 0.80920985 |
| 116 | MP0001545_abnormal_hematopoietic_system | 0.80920985 |
| 117 | MP0002896_abnormal_bone_mineralization | 0.80692975 |
| 118 | * MP0001614_abnormal_blood_vessel | 0.79277972 |
| 119 | MP0001542_abnormal_bone_strength | 0.78690571 |
| 120 | MP0004484_altered_response_of | 0.77384422 |
| 121 | MP0004036_abnormal_muscle_relaxation | 0.77125215 |
| 122 | MP0004858_abnormal_nervous_system | 0.76514610 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Protrusio acetabuli (HP:0003179) | 4.81569419 |
| 2 | Premature rupture of membranes (HP:0001788) | 4.44793568 |
| 3 | * Aortic dissection (HP:0002647) | 3.96436263 |
| 4 | Ankle contracture (HP:0006466) | 3.74250877 |
| 5 | Broad metatarsal (HP:0001783) | 3.72721105 |
| 6 | * Cerebral aneurysm (HP:0004944) | 3.68182391 |
| 7 | Hematochezia (HP:0002573) | 3.60187666 |
| 8 | * Aortic aneurysm (HP:0004942) | 3.53270440 |
| 9 | Systemic lupus erythematosus (HP:0002725) | 3.40794098 |
| 10 | Osteolytic defects of the hand bones (HP:0009699) | 3.33081061 |
| 11 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 3.33081061 |
| 12 | Atrophic scars (HP:0001075) | 3.26543807 |
| 13 | Spondylolisthesis (HP:0003302) | 3.25035369 |
| 14 | Shallow orbits (HP:0000586) | 3.22334390 |
| 15 | Deep venous thrombosis (HP:0002625) | 3.12076547 |
| 16 | * Mitral valve prolapse (HP:0001634) | 3.11428288 |
| 17 | Cervical subluxation (HP:0003308) | 3.07614940 |
| 18 | Spontaneous hematomas (HP:0007420) | 2.96405101 |
| 19 | Peritonitis (HP:0002586) | 2.83126914 |
| 20 | * Dilatation of the ascending aorta (HP:0005111) | 2.70226538 |
| 21 | Interstitial pulmonary disease (HP:0006530) | 2.63602257 |
| 22 | Increased connective tissue (HP:0009025) | 2.63184244 |
| 23 | Eczematoid dermatitis (HP:0000976) | 2.58325959 |
| 24 | Myocardial infarction (HP:0001658) | 2.55068039 |
| 25 | Soft skin (HP:0000977) | 2.54654730 |
| 26 | Orchitis (HP:0100796) | 2.53250793 |
| 27 | Dysostosis multiplex (HP:0000943) | 2.49720583 |
| 28 | Menorrhagia (HP:0000132) | 2.47640617 |
| 29 | Ulnar bowing (HP:0003031) | 2.45436009 |
| 30 | Hemorrhage of the eye (HP:0011885) | 2.45397997 |
| 31 | Type 1 muscle fiber predominance (HP:0003803) | 2.44981821 |
| 32 | Abnormality of the nasal mucosa (HP:0000433) | 2.43003982 |
| 33 | Joint hemorrhage (HP:0005261) | 2.42785257 |
| 34 | Glomerulonephritis (HP:0000099) | 2.42561177 |
| 35 | Fragile skin (HP:0001030) | 2.41165950 |
| 36 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.39700171 |
| 37 | Increased density of long bones (HP:0006392) | 2.39626682 |
| 38 | Complement deficiency (HP:0004431) | 2.32187544 |
| 39 | Amyloidosis (HP:0011034) | 2.30641525 |
| 40 | * Aneurysm (HP:0002617) | 2.29549492 |
| 41 | Wrist flexion contracture (HP:0001239) | 2.27959975 |
| 42 | Camptodactyly of toe (HP:0001836) | 2.26038270 |
| 43 | Follicular hyperkeratosis (HP:0007502) | 2.24973554 |
| 44 | Nephritis (HP:0000123) | 2.24385471 |
| 45 | Persistence of primary teeth (HP:0006335) | 2.20340149 |
| 46 | Bladder diverticulum (HP:0000015) | 2.19278897 |
| 47 | Genu recurvatum (HP:0002816) | 2.17908876 |
| 48 | Gingival bleeding (HP:0000225) | 2.15507533 |
| 49 | Mitral stenosis (HP:0001718) | 2.15124063 |
| 50 | Epistaxis (HP:0000421) | 2.14866941 |
| 51 | Polycythemia (HP:0001901) | 2.14407697 |
| 52 | Increased cerebral lipofuscin (HP:0011813) | 2.13160225 |
| 53 | Nonimmune hydrops fetalis (HP:0001790) | 2.12729335 |
| 54 | Abnormality of macrophages (HP:0004311) | 2.12255302 |
| 55 | Thin bony cortex (HP:0002753) | 2.11933072 |
| 56 | Gastrointestinal infarctions (HP:0005244) | 2.11730458 |
| 57 | Vertebral compression fractures (HP:0002953) | 2.11278763 |
| 58 | Mucopolysacchariduria (HP:0008155) | 2.11176620 |
| 59 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.11176620 |
| 60 | Gingivitis (HP:0000230) | 2.10012045 |
| 61 | Emphysema (HP:0002097) | 2.08754834 |
| 62 | * Blue sclerae (HP:0000592) | 2.08474008 |
| 63 | * Vascular tortuosity (HP:0004948) | 2.07726424 |
| 64 | Abnormality of the common coagulation pathway (HP:0010990) | 2.07348526 |
| 65 | Colitis (HP:0002583) | 2.05984090 |
| 66 | Wormian bones (HP:0002645) | 2.04796181 |
| 67 | Cardiovascular calcification (HP:0011915) | 2.03963152 |
| 68 | Autoimmune thrombocytopenia (HP:0001973) | 2.03759195 |
| 69 | Slender build (HP:0001533) | 2.02443701 |
| 70 | Flat acetabular roof (HP:0003180) | 2.01394199 |
| 71 | Prolonged bleeding time (HP:0003010) | 1.99483686 |
| 72 | Myositis (HP:0100614) | 1.98863860 |
| 73 | * Disproportionate tall stature (HP:0001519) | 1.98499428 |
| 74 | Spinal rigidity (HP:0003306) | 1.98373060 |
| 75 | Abnormality of complement system (HP:0005339) | 1.98144412 |
| 76 | * Striae distensae (HP:0001065) | 1.97460250 |
| 77 | Cellulitis (HP:0100658) | 1.97083918 |
| 78 | Retrobulbar optic neuritis (HP:0100654) | 1.96890825 |
| 79 | Optic neuritis (HP:0100653) | 1.96890825 |
| 80 | Mitral regurgitation (HP:0001653) | 1.95878365 |
| 81 | Pustule (HP:0200039) | 1.95293671 |
| 82 | Joint stiffness (HP:0001387) | 1.94439453 |
| 83 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.94306790 |
| 84 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.94306790 |
| 85 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.94306790 |
| 86 | * Arterial tortuosity (HP:0005116) | 1.94250830 |
| 87 | Ovoid vertebral bodies (HP:0003300) | 1.94133341 |
| 88 | Abnormality of the acetabulum (HP:0003170) | 1.93748602 |
| 89 | Recurrent abscess formation (HP:0002722) | 1.92991391 |
| 90 | Coxa vara (HP:0002812) | 1.92349352 |
| 91 | Subacute progressive viral hepatitis (HP:0006572) | 1.92039738 |
| 92 | Vacuolated lymphocytes (HP:0001922) | 1.91049218 |
| 93 | Ectopia lentis (HP:0001083) | 1.90903048 |
| 94 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.89508357 |
| 95 | Esophageal varix (HP:0002040) | 1.89456670 |
| 96 | Abnormality of carpal bone ossification (HP:0006257) | 1.88825012 |
| 97 | Recurrent bronchitis (HP:0002837) | 1.88775125 |
| 98 | Chronic otitis media (HP:0000389) | 1.87775564 |
| 99 | Asymmetric septal hypertrophy (HP:0001670) | 1.86541892 |
| 100 | Absent frontal sinuses (HP:0002688) | 1.85061019 |
| 101 | Pulmonary infiltrates (HP:0002113) | 1.82926948 |
| 102 | Inflammation of the large intestine (HP:0002037) | 1.82843969 |
| 103 | Abnormality of the peritoneum (HP:0002585) | 1.82698071 |
| 104 | Aortic regurgitation (HP:0001659) | 1.81682788 |
| 105 | Overgrowth (HP:0001548) | 1.81545668 |
| 106 | Flexion contracture of toe (HP:0005830) | 1.81241615 |
| 107 | Joint contractures involving the joints of the feet (HP:0100492) | 1.81241615 |
| 108 | Distal lower limb muscle weakness (HP:0009053) | 1.80589894 |
| 109 | Increased variability in muscle fiber diameter (HP:0003557) | 1.79164824 |
| 110 | Nasal polyposis (HP:0100582) | 1.78647887 |
| 111 | Recurrent bacterial skin infections (HP:0005406) | 1.78503428 |
| 112 | Bowing of the arm (HP:0006488) | 1.78294297 |
| 113 | Bowed forearm bones (HP:0003956) | 1.78294297 |
| 114 | Broad face (HP:0000283) | 1.78007355 |
| 115 | Right ventricular cardiomyopathy (HP:0011663) | 1.77897022 |
| 116 | Glucose intolerance (HP:0000833) | 1.76472918 |
| 117 | Gastrointestinal inflammation (HP:0004386) | 1.75721961 |
| 118 | Radial bowing (HP:0002986) | 1.75313266 |
| 119 | Abnormal platelet volume (HP:0011876) | 1.74757291 |
| 120 | Abnormal ossification of hand bones (HP:0005921) | 1.74729521 |
| 121 | Arterial thrombosis (HP:0004420) | 1.73981216 |
| 122 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.73877161 |
| 123 | Short nail (HP:0001799) | 1.73720257 |
| 124 | * Joint laxity (HP:0001388) | 1.73181379 |
| 125 | Conjunctival telangiectasia (HP:0000524) | 1.72759496 |
| 126 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.71780867 |
| 127 | Distal lower limb amyotrophy (HP:0008944) | 1.71616874 |
| 128 | Syringomyelia (HP:0003396) | 1.71226567 |
| 129 | Spinal cord lesions (HP:0100561) | 1.71226567 |
| 130 | Mesangial abnormality (HP:0001966) | 1.70573350 |
| 131 | Purpura (HP:0000979) | 1.70323117 |
| 132 | Elbow flexion contracture (HP:0002987) | 1.69926736 |
| 133 | Skin nodule (HP:0200036) | 1.69879189 |
| 134 | Flared iliac wings (HP:0002869) | 1.69606862 |
| 135 | Thick nail (HP:0001805) | 1.69599139 |
| 136 | Increased mean platelet volume (HP:0011877) | 1.69556535 |
| 137 | Keratoconjunctivitis sicca (HP:0001097) | 1.68170611 |
| 138 | Hypertriglyceridemia (HP:0002155) | 1.67921759 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIB3 | 3.29125555 |
| 2 | ERN1 | 2.97766645 |
| 3 | MAP4K1 | 2.92711544 |
| 4 | TTN | 2.91241968 |
| 5 | * TGFBR2 | 2.76069238 |
| 6 | PKN2 | 2.45116721 |
| 7 | STK10 | 2.30175689 |
| 8 | KDR | 2.24506992 |
| 9 | PRPF4B | 2.14995423 |
| 10 | TIE1 | 2.08731573 |
| 11 | FGFR4 | 2.08082732 |
| 12 | TYK2 | 2.04369894 |
| 13 | EPHB1 | 2.02932378 |
| 14 | MAP3K10 | 2.00065949 |
| 15 | JAK1 | 1.93178961 |
| 16 | SIK1 | 1.89114481 |
| 17 | LRRK2 | 1.84264038 |
| 18 | EEF2K | 1.80661488 |
| 19 | FES | 1.76943301 |
| 20 | RIPK1 | 1.75331300 |
| 21 | JAK3 | 1.70900903 |
| 22 | PTK6 | 1.67129526 |
| 23 | CAMK1D | 1.61714153 |
| 24 | PDGFRA | 1.61624352 |
| 25 | ZAP70 | 1.58575277 |
| 26 | BLK | 1.55626571 |
| 27 | ITK | 1.54697687 |
| 28 | TBK1 | 1.53264587 |
| 29 | FGFR3 | 1.52055120 |
| 30 | EPHA3 | 1.44734069 |
| 31 | PAK4 | 1.42786644 |
| 32 | CSF1R | 1.42272262 |
| 33 | MAP2K3 | 1.38453919 |
| 34 | CDC42BPA | 1.37123345 |
| 35 | DMPK | 1.34190895 |
| 36 | CSK | 1.32789947 |
| 37 | MAP3K13 | 1.27643691 |
| 38 | KIT | 1.25097298 |
| 39 | RIPK4 | 1.23666047 |
| 40 | MAP3K3 | 1.22409993 |
| 41 | CAMK1G | 1.21623382 |
| 42 | NEK9 | 1.18512219 |
| 43 | DDR2 | 1.16215560 |
| 44 | MAP3K6 | 1.13832380 |
| 45 | ICK | 1.13258715 |
| 46 | MAP3K1 | 1.06918131 |
| 47 | TRPM7 | 1.05653051 |
| 48 | KSR2 | 1.05461090 |
| 49 | HCK | 1.04399429 |
| 50 | RPS6KA4 | 1.00593947 |
| 51 | MAP3K14 | 1.00099242 |
| 52 | PDGFRB | 0.99357346 |
| 53 | PAK2 | 0.98388995 |
| 54 | IKBKE | 0.97224667 |
| 55 | EPHB2 | 0.96630056 |
| 56 | TGFBR1 | 0.96149170 |
| 57 | GRK6 | 0.95395143 |
| 58 | STK38 | 0.94792383 |
| 59 | TXK | 0.93400970 |
| 60 | LATS1 | 0.91238559 |
| 61 | PDPK1 | 0.91170984 |
| 62 | SMG1 | 0.90124640 |
| 63 | PRKCH | 0.88415293 |
| 64 | BTK | 0.87393918 |
| 65 | NLK | 0.87273887 |
| 66 | MARK2 | 0.86657617 |
| 67 | MAP3K2 | 0.86324091 |
| 68 | JAK2 | 0.82649732 |
| 69 | BMX | 0.82648199 |
| 70 | CHUK | 0.82242766 |
| 71 | PTK2 | 0.81725963 |
| 72 | CDK6 | 0.81593234 |
| 73 | MYLK | 0.80951321 |
| 74 | FGFR2 | 0.80032041 |
| 75 | TEC | 0.79595694 |
| 76 | IKBKB | 0.79305806 |
| 77 | NTRK1 | 0.78361399 |
| 78 | LCK | 0.75839934 |
| 79 | MARK3 | 0.75343522 |
| 80 | MET | 0.73457904 |
| 81 | STK3 | 0.71594803 |
| 82 | PTK2B | 0.70855320 |
| 83 | MAP3K7 | 0.70627048 |
| 84 | PRKG2 | 0.69371115 |
| 85 | CDK12 | 0.67270948 |
| 86 | MAPK7 | 0.66811122 |
| 87 | SGK3 | 0.65052333 |
| 88 | FER | 0.64935695 |
| 89 | PDK1 | 0.64482417 |
| 90 | WNK1 | 0.62682653 |
| 91 | PRKD1 | 0.61781670 |
| 92 | TESK1 | 0.61560156 |
| 93 | MAP3K11 | 0.60797801 |
| 94 | PRKAA2 | 0.59105711 |
| 95 | FGR | 0.58135449 |
| 96 | MST1R | 0.57367445 |
| 97 | MST4 | 0.57218680 |
| 98 | IRAK1 | 0.57047782 |
| 99 | CDK9 | 0.56741659 |
| 100 | PRKD2 | 0.56380996 |
| 101 | ILK | 0.55768091 |
| 102 | IRAK3 | 0.55749612 |
| 103 | MAPK12 | 0.55254561 |
| 104 | MELK | 0.55101043 |
| 105 | INSR | 0.54992483 |
| 106 | HIPK2 | 0.54832847 |
| 107 | MTOR | 0.54677855 |
| 108 | FRK | 0.54058615 |
| 109 | LATS2 | 0.53346943 |
| 110 | PIK3CG | 0.53060601 |
| 111 | RPS6KA2 | 0.51372555 |
| 112 | GSK3A | 0.51341880 |
| 113 | IGF1R | 0.50617897 |
| 114 | MAPK15 | 0.50603578 |
| 115 | SCYL2 | 0.50537062 |
| 116 | FLT3 | 0.50498074 |
| 117 | CLK1 | 0.50218966 |
| 118 | IRAK4 | 0.49785259 |
| 119 | MAPK11 | 0.49129107 |
| 120 | EGFR | 0.49108867 |
| 121 | RET | 0.48605268 |
| 122 | MOS | 0.48417246 |
| 123 | FGFR1 | 0.48144179 |
| 124 | LMTK2 | 0.47356110 |
| 125 | CAMKK2 | 0.47008757 |
| 126 | SYK | 0.46783751 |
| 127 | MAPKAPK3 | 0.46731606 |
| 128 | TAOK2 | 0.46699461 |
| 129 | PIM1 | 0.46689766 |
| 130 | EPHA2 | 0.41376402 |
| 131 | ABL1 | 0.40772212 |
| 132 | MAPKAPK2 | 0.40270348 |
| 133 | NUAK1 | 0.39364167 |
| 134 | LYN | 0.38980922 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.39274590 |
| 2 | ECM-receptor interaction_Homo sapiens_hsa04512 | 2.26760456 |
| 3 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.18358862 |
| 4 | * Osteoclast differentiation_Homo sapiens_hsa04380 | 2.07760092 |
| 5 | Leishmaniasis_Homo sapiens_hsa05140 | 2.01472869 |
| 6 | Focal adhesion_Homo sapiens_hsa04510 | 1.93901095 |
| 7 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.87293630 |
| 8 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.86862331 |
| 9 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.85321569 |
| 10 | * AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.84314612 |
| 11 | Malaria_Homo sapiens_hsa05144 | 1.82899228 |
| 12 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.65152902 |
| 13 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.65062530 |
| 14 | Other glycan degradation_Homo sapiens_hsa00511 | 1.65012373 |
| 15 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.60005773 |
| 16 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.58510893 |
| 17 | Amoebiasis_Homo sapiens_hsa05146 | 1.55367067 |
| 18 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.55231879 |
| 19 | Viral myocarditis_Homo sapiens_hsa05416 | 1.53551751 |
| 20 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.53353104 |
| 21 | Lysosome_Homo sapiens_hsa04142 | 1.51983136 |
| 22 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.49469324 |
| 23 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.43118483 |
| 24 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.41847095 |
| 25 | * Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.41771296 |
| 26 | Measles_Homo sapiens_hsa05162 | 1.41365857 |
| 27 | Pertussis_Homo sapiens_hsa05133 | 1.41025437 |
| 28 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.38911584 |
| 29 | Platelet activation_Homo sapiens_hsa04611 | 1.37553719 |
| 30 | * Adherens junction_Homo sapiens_hsa04520 | 1.31811617 |
| 31 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.30395140 |
| 32 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.29252040 |
| 33 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.27721667 |
| 34 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.26629246 |
| 35 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.26487217 |
| 36 | * Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.24235100 |
| 37 | * Pancreatic cancer_Homo sapiens_hsa05212 | 1.23812472 |
| 38 | Tuberculosis_Homo sapiens_hsa05152 | 1.21113443 |
| 39 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.16958172 |
| 40 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.15843513 |
| 41 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.12362113 |
| 42 | Shigellosis_Homo sapiens_hsa05131 | 1.11512038 |
| 43 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.10588782 |
| 44 | Apoptosis_Homo sapiens_hsa04210 | 1.09313804 |
| 45 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.09212131 |
| 46 | Hepatitis B_Homo sapiens_hsa05161 | 1.07206704 |
| 47 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 1.05048502 |
| 48 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.04154723 |
| 49 | Salmonella infection_Homo sapiens_hsa05132 | 1.02003548 |
| 50 | Legionellosis_Homo sapiens_hsa05134 | 0.97856844 |
| 51 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.97490953 |
| 52 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.97127553 |
| 53 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.96561644 |
| 54 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.95503049 |
| 55 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.93239529 |
| 56 | Insulin resistance_Homo sapiens_hsa04931 | 0.92915964 |
| 57 | * Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.92054620 |
| 58 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.91949061 |
| 59 | Influenza A_Homo sapiens_hsa05164 | 0.89375013 |
| 60 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.89131859 |
| 61 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.87643440 |
| 62 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.87331646 |
| 63 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.86952342 |
| 64 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.86081772 |
| 65 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.85670215 |
| 66 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.85444298 |
| 67 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.85101939 |
| 68 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.84959607 |
| 69 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.79069992 |
| 70 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.75733711 |
| 71 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.75186262 |
| 72 | * HTLV-I infection_Homo sapiens_hsa05166 | 0.75180826 |
| 73 | Hepatitis C_Homo sapiens_hsa05160 | 0.75084327 |
| 74 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.75047569 |
| 75 | * Endocytosis_Homo sapiens_hsa04144 | 0.74981697 |
| 76 | Thyroid cancer_Homo sapiens_hsa05216 | 0.74180431 |
| 77 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.72038179 |
| 78 | Allograft rejection_Homo sapiens_hsa05330 | 0.71784621 |
| 79 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.71746349 |
| 80 | * Pathways in cancer_Homo sapiens_hsa05200 | 0.70563084 |
| 81 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.69814475 |
| 82 | Prostate cancer_Homo sapiens_hsa05215 | 0.68255553 |
| 83 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.66602700 |
| 84 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.66111554 |
| 85 | Phagosome_Homo sapiens_hsa04145 | 0.65429428 |
| 86 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.64925643 |
| 87 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.64600738 |
| 88 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.63629410 |
| 89 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.63031387 |
| 90 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.62830587 |
| 91 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.62547352 |
| 92 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.62425498 |
| 93 | * Colorectal cancer_Homo sapiens_hsa05210 | 0.62185885 |
| 94 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.61834968 |
| 95 | Bladder cancer_Homo sapiens_hsa05219 | 0.61021201 |
| 96 | Prion diseases_Homo sapiens_hsa05020 | 0.59372588 |
| 97 | * TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.58389323 |
| 98 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.57908359 |
| 99 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.57791254 |
| 100 | * Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.57752063 |
| 101 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.56508830 |
| 102 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.56446648 |
| 103 | Endometrial cancer_Homo sapiens_hsa05213 | 0.56262411 |
| 104 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.55904407 |
| 105 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.55024428 |
| 106 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.51578347 |
| 107 | * FoxO signaling pathway_Homo sapiens_hsa04068 | 0.51200091 |
| 108 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.51102233 |
| 109 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.51027375 |
| 110 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.50995236 |
| 111 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.50344140 |
| 112 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.50330816 |
| 113 | Glioma_Homo sapiens_hsa05214 | 0.50125640 |
| 114 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.47393811 |
| 115 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.46924545 |
| 116 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.45403482 |
| 117 | Lysine degradation_Homo sapiens_hsa00310 | 0.43573019 |

